The Annals New | Pharmaco Epidemiology and Therapeutic Risk Management
home help contact us subscription past issues search current issue
 QUICK SEARCH:   [advanced]


     


The Annals of Pharmacotherapy: Vol. 31, No. 6, pp. 733-735.
© 1997 Harvey Whitney Books Company.
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bentur, L
Right arrow Articles by Bentur, Y
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bentur, L
Right arrow Articles by Bentur, Y


Research Articles

Severe minocycline-induced eosinophilic pneumonia: extrapulmonary manifestations and the use of in vitro immunoassays

L Bentur, Y Bar-Kana, E Livni, R Finkelstein, O Ben-Izhak, S Keidar, and Y Bentur

OBJECTIVE: To report a severe and unusual reaction to minocycline and the use of in vitro immunologic assays. CASE SUMMARY: A 46-year-old white man developed severe respiratory distress with pulmonary infiltrates on chest X-ray and eosinophilia in blood, bronchoalveolar lavage fluid, and biopsied lung tissue during exposure to minocycline. Additional manifestations included pleuropericardial effusion, liver function abnormality, and bone marrow eosinophilia. Macrophage inhibition factor and mast cell degranulation assays were positive to minocycline. DISCUSSION: The patient's manifestations were compatible with the diagnosis of eosinophilic pneumonia. After excluding other possible etiologies, minocycline was identified as the offending agent. Generalized damage was suggested by the presence of a combination of extrapulmonary manifestations previously not reported. Results of the in vitro immunologic assays supported the hypersensitivity nature of the disease and confirmed the diagnosis. CONCLUSIONS: Minocycline-induced eosinophilic pneumonia may involve extrapulmonary sites. It is suggested that in vitro immunoassays be used for confirmation of the diagnosis rather than rechallenge or invasive procedures.


This article has been cited by other articles:


Home page
ChestHome page
M. I. Schwarz and R. K. Albert
"Imitators" of the ARDS: Implications for Diagnosis and Treatment
Chest, April 1, 2004; 125(4): 1530 - 1535.
[Full Text] [PDF]


Home page
ChestHome page
M. Oddo, L. Liaudet, M. Lepori, A. F. Broccard, and M.-D. Schaller
Relapsing Acute Respiratory Failure Induced by Minocycline
Chest, June 1, 2003; 123(6): 2146 - 2148.
[Abstract] [Full Text] [PDF]


Home page
Postgrad. Med. J.Home page
P. Davey and D. G Lalloo
Drug induced chest pain---rare but important
Postgrad. Med. J., July 1, 2000; 76(897): 420 - 422.
[Abstract] [Full Text]




homecopy help contact us subscription past issues search current issue
Copyright © 1997 by Harvey Whitney Books Company.